1. Further action taken in ongoing EU review of "sartan" products

   News item 27 October 2018 Pages: 1 - 1

2. Interaction between ritonavir products and levothyroxine

   News item 27 October 2018 Pages: 2 - 2

3. Postmarketing cases of PRES with ponatinib: MHRA advice

   News item 27 October 2018 Pages: 3 - 3

4. Sildenafil products not to be used for treatment of IUGR

   Correspondence 27 October 2018 Pages: 4 - 4

5. Use of artificial intelligence to create AE case reports

   Clinical study 27 October 2018 Pages: 5 - 5

6. Voluntary recall of ReGen stem cell products in US

   News item 27 October 2018 Pages: 6 - 6

7. Support for tighter control of pregabalin and gabapentin in UK

   Comment 27 October 2018 Pages: 7 - 7

8. Benzodiazepines increase risk of suicide in patients with COPD

   Clinical study 27 October 2018 Pages: 8 - 8

9. Exercise reduces vaccination-related AEs

   Clinical study 27 October 2018 Pages: 9 - 9

10. More thromboembolic events with warfarin after cardioversion

    Clinical study 27 October 2018 Pages: 10 - 10

11. Pre-fluoropyrimidine genotyping saves toxicity-related costs

    Clinical study 27 October 2018 Pages: 11 - 11

12. Unapproved pharmaceutical ingredients in dietary supplements

    Clinical study 27 October 2018 Pages: 12 - 12

13. Abciximab

    Case report 27 October 2018 Pages: 13 - 13

14. Acenocoumarol

    Case report 27 October 2018 Pages: 14 - 14

15. Acenocoumarol

    Case report 27 October 2018 Pages: 15 - 15

16. Acetazolamide

    Case report 27 October 2018 Pages: 16 - 16

17. Acetylcysteine

    Case report 27 October 2018 Pages: 17 - 17

18. Adalimumab

    Case report 27 October 2018 Pages: 18 - 18

19. Adalimumab

    Case report 27 October 2018 Pages: 19 - 19

20. Adenosine

    Case report 27 October 2018 Pages: 20 - 20

21. Aflibercept

    Case report 27 October 2018 Pages: 21 - 21

22. Alcohol/metformin interaction

    Case report 27 October 2018 Pages: 22 - 22

23. Alendronic acid

    Case report 27 October 2018 Pages: 23 - 23

24. Allopurinol

    Case report 27 October 2018 Pages: 24 - 24

25. Allopurinol/ciprofloxacin/vancomycin

    Case report 27 October 2018 Pages: 25 - 25

26. Amikacin

    Case report 27 October 2018 Pages: 26 - 26

27. Anastrozole/clomifene

    Case report 27 October 2018 Pages: 27 - 27

28. Anti-bacterial/anti-fungal

    Case report 27 October 2018 Pages: 28 - 28

29. Anti-inflammatories/metoprolol/rosuvastatin

    Case report 27 October 2018 Pages: 29 - 29

30. Antifungals

    Case report 27 October 2018 Pages: 30 - 30

31. Antihypertensives

    Case report 27 October 2018 Pages: 31 - 31

32. Antineoplastics

    Case report 27 October 2018 Pages: 32 - 32

33. Antineoplastics

    Case report 27 October 2018 Pages: 33 - 33

34. Antineoplastics

    Case report 27 October 2018 Pages: 34 - 34

35. Antineoplastics

    Case report 27 October 2018 Pages: 35 - 35

36. Antineoplastics

    Case report 27 October 2018 Pages: 36 - 36

37. Antineoplastics

    Case report 27 October 2018 Pages: 37 - 37

38. Antineoplastics

    Case report 27 October 2018 Pages: 38 - 38

39. Antineoplastics

    Case report 27 October 2018 Pages: 39 - 39

40. Antineoplastics

    Case report 27 October 2018 Pages: 40 - 40

41. Antineoplastics/immunosuppressants

    Case report 27 October 2018 Pages: 41 - 41

42. Apixaban

    Case report 27 October 2018 Pages: 42 - 42

43. Argatroban

    Case report 27 October 2018 Pages: 43 - 43

44. Asfotase-α

    Case report 27 October 2018 Pages: 44 - 44

45. Asparaginase

    Case report 27 October 2018 Pages: 45 - 45

46. Asparaginase/dexamethasone/prednisolone

    Case report 27 October 2018 Pages: 46 - 46

47. Aspirin

    Case report 27 October 2018 Pages: 47 - 47

48. Aspirin/low molecular weight heparin

    Case report 27 October 2018 Pages: 48 - 48

49. Aspirin/quetiapine

    Case report 27 October 2018 Pages: 49 - 49

50. Atenolol

    Case report 27 October 2018 Pages: 50 - 50